GREY:MDCGF - Post by User
Comment by
wizwizon Nov 30, 2009 5:27pm
202 Views
Post# 16537694
RE: 15 days / trading
RE: 15 days / tradingItremains 15 days of trading before the week of 21, was 2 days startingthat will give us action, December 8 for World Influenza and the 14 or15 before the opening or Philip Morris will use his s right of first refusal, he wants to become majority shareholder in MDG. Isee a $ .80 if no other news before the release of results and if wehave other good news and could be ready the $ 1 and after thesuccessful Phase 1, the quality of results is dictated the value of the future, action. Currently, there has been a successful Phase 1 will allow a closer of MDG 3 deal starting:
Genopole, Ajanta, Tabuk and most of Quebec's Lab is ready to manufacture 60 million doses per year
Do a little quick calculation:
Genopole: 60 million doses per year
Tabuk: 60 million doses per year
Ajanta: 60 million doses per year
Quebec: 60 million doses per year
= 240 million doses have a minimum price of $ 1 per dose.
Ihave based the amount of dose produced a year because when I called theother day she m, said that the LAB and Quebec will Génopole 60 milliondoses per year. So we can suspect that Ajanta and Tabuk will produce the same amount if not more. forthe price I was really at its minimum because their costs about $ .50 /doses, while the competition is between $ .89 and $ 2 per dose.
Make your calculations when s is that GSK has sold $ 8 a dose to Canada. Theamount of new agreements will depend on the quality of the results ofPhase 1 and do not forget that the MDGs and the only company 100%successful in its experiment with animals.
It costs GSK $1 per dose and they charge the gov't $8 per dose. An 800% mark up is pretty good. If and when MDG gets their vaccine produced in quantity, you can be sure GSK and everyone else will drop their prices dramatically or buy out MDG immediately so they don't have to lower their prices. GSK doesn't even have to use the MDG process. They just have to stop someone else from undercutting their prices and this includes curtailing the building of the foreign MDG factories as well. The drug manufacturers are all about making a profit, not about saving mankind by producing cost effective drugs. If MDG becomes a threat to their pricing, they will be taken out.
Wiz